Who owns ABEONA THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Abeona Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Abeona Therapeutics stock

Who bought or sold ABEONA THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Nantahala Capital Management 2.8M $14M 18% Dec 2023
 View chart
Millennium Management 1.4M $7.1M 37% Dec 2023
 View chart
Vanguard Group 1.1M $5.5M 46% Dec 2023
 View chart
Western Standard 808k $4.0M 261% Dec 2023
 View chart
AIGH Capital Management 788k $3.9M -31% Dec 2023
 View chart
Point72 Asset Management 761k $3.8M -36% Dec 2023
 View chart
Ikarian Capital 600k $3.0M 100% Dec 2023
 View chart
Citigroup 450k $2.3M 0% Dec 2023
 View chart
J. Goldman & Co 430k $2.2M -13% Dec 2023
 View chart
Worth Venture Partners 196k $984k -30% Dec 2023
 View chart
Walleye Trading Advisors 188k $942k 100% Dec 2023
 View chart
Barclays 170k $850k -54% Dec 2023
 View chart
Bank of New York Mellon 119k $863k 794% Mar 2024
 View chart
Citadel Advisors 110k $553k 100% Dec 2023
 View chart
Alyeska Investment Group 70k $351k 100% Dec 2023
 View chart
Two Sigma Investments 57k $285k 100% Dec 2023
 View chart
Bank of America Corporation 51k $256k 100% Dec 2023
 View chart
Marshall Wace 48k $240k 100% Dec 2023
 View chart
Jane Street 41k $205k 100% Dec 2023
 View chart
Jump Financial 40k $199k 100% Dec 2023
 View chart
Palumbo Wealth Management 14k $104k 100% Mar 2024
 View chart
CI Private Wealth 14k $70k 0% Dec 2023
 View chart
Squarepoint Ops 10k $50k 100% Dec 2023
 View chart
Advisor Group Holdings 2.6k $13k -2% Dec 2023
 View chart
Simplex Trading 2.2k $15k -55% Mar 2024
 View chart
Royal Bank of Canada 1.0k $4.8k 14314% Dec 2023
 View chart
Hartford Financial Management 720.00 $5.2k 0% Mar 2024
 View chart
Parallel Advisors 400.00 $2.0k 0% Dec 2023
 View chart
Wells Fargo & Company 237.00 $1.2k 41% Dec 2023
 View chart
Rhumbline Advisers 58.00 $290.000000 0% Dec 2023
 View chart
Jpmorgan Chase & Co 14.00 $70.000000 0% Dec 2023
 View chart
Highlander Capital Management 1.00 $5.000000 0% Dec 2023
 View chart

Who sold out of Abeona Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Schonfeld Strategic Advisors Sep 2023 154k $648k
Creative Planning Sep 2023 14k $59k
GSA Capital Partners Sep 2023 12k $49k
Dimensional Fund Advisors Sep 2023 11k $47k
UBS Group Sep 2023 1.1k $4.5k
Cambridge Trust Company Sep 2023 13.00 $55.000400